Table of Content

"1    INTRODUCTION    30
1.1    OBJECTIVES OF THE STUDY    30
1.2    MARKET DEFINITION    30
1.2.1    INCLUSIONS & EXCLUSIONS    30
1.3    MARKET SCOPE    31
1.3.1    MARKETS COVERED    31
FIGURE 1    GASTROINTESTINAL STENT MARKET    31
1.3.2    YEARS CONSIDERED FOR STUDY    31
1.4    CURRENCY    32
TABLE 1    STANDARD CURRENCY CONVERSION RATES    32
1.5    LIMITATIONS    33
1.6    STAKEHOLDERS    33
1.7    SUMMARY OF CHANGES    34
2    RESEARCH METHODOLOGY    35
2.1    RESEARCH APPROACH    35
FIGURE 2    GASTROINTESTINAL STENT MARKET: RESEARCH METHODOLOGY STEPS    35
FIGURE 3    RESEARCH DESIGN    36
2.1.1    SECONDARY DATA    36
2.1.1.1    Key data from secondary sources    37
2.1.2    PRIMARY DATA    38
FIGURE 4    PRIMARY SOURCES    39
2.1.2.1    Key data from primary sources    40
2.1.2.2    Key industry insights    40
FIGURE 5    BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS (GASTROINTESTINAL STENT MARKET)    41
FIGURE 6    BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION    41
2.2    MARKET SIZE ESTIMATION    41
FIGURE 7    SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS    42
FIGURE 8    REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION    42
FIGURE 9    SUPPLY SIDE MARKET SIZE ESTIMATION: GASTROINTESTINAL STENT MARKET (2020)    43
FIGURE 10    CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS    44
FIGURE 11    CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR GASTROINTESTINAL STENT MARKET (2021–2026)    44
FIGURE 12    TOP-DOWN APPROACH    45

2.3    MARKET BREAKDOWN & DATA TRIANGULATION    46
FIGURE 13    MARKET DATA TRIANGULATION METHODOLOGY    46
2.4    ASSUMPTIONS FOR THE STUDY    47
2.5    LIMITATIONS    47
2.5.1    METHODOLOGY-RELATED LIMITATIONS    47
2.6    RISK ASSESSMENT    48
2.7    ASSESSMENT OF IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET    48
3    EXECUTIVE SUMMARY    49
FIGURE 14    GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION)    49
FIGURE 15    GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2021 VS. 2026 (USD MILLION)    50
FIGURE 16    GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)    51
FIGURE 17    GASTROINTESTINAL STENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)    51
FIGURE 18    GEOGRAPHIC SNAPSHOT OF GASTROINTESTINAL STENT MARKET    52
4    PREMIUM INSIGHTS    53
4.1    GASTROINTESTINAL STENT MARKET OVERVIEW    53
FIGURE 19    RISE IN INCIDENCE OF GASTROINTESTINAL CANCERS, IBD, AND OTHER DIGESTIVE DISEASES DRIVE GASTROINTESTINAL STENT MARKET GROWTH    53
4.2    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT AND COUNTRY    54
FIGURE 20    BILIARY STENT HELD LARGEST SHARE OF NORTH AMERICAN MARKET
IN 2020    54
4.3    GASTROINTESTINAL STENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES    55
FIGURE 21    CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD    55
4.4    GASTROINTESTINAL STENT MARKET: REGIONAL MIX    55
FIGURE 22    NORTH AMERICA TO BE LARGEST MARKET FOR GASTROINTESTINAL
STENT THROUGHOUT FORECAST PERIOD    55
5    MARKET OVERVIEW    56
5.1    INTRODUCTION    56
5.2    MARKET DYNAMICS    56
FIGURE 23    GASTROINTESTINAL STENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    56
5.2.1    DRIVERS    57
5.2.1.1    Rise in the incidence of gastrointestinal cancers, IBD, and
other digestive diseases    57
TABLE 2    GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020    57
TABLE 3    GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020    57
5.2.1.2    Increasing healthcare expenditure on gastrointestinal procedures    58
FIGURE 24    EUROPE: COSTS OF GASTROINTESTINAL CANCERS (USD BILLION), 2018    58
5.2.1.3    Ongoing technological advancements in business space    59
5.2.1.4    Increasing preference for minimally invasive surgeries    59
5.2.2    RESTRAINTS    60
5.2.2.1    Major complications associated with GI stent implementation    60
TABLE 4    FREQUENCY OF MOST COMMON STENT-RELATED COMPLICATIONS IN VARIOUS ANATOMIC SITES    60
5.2.2.2    High cost of the procedure and limited reimbursement in
developing countries    61
5.2.3    OPPORTUNITIES    61
5.2.3.1    Development of biodegradable and drug eluting stents    61
5.2.3.2    Growing healthcare sector in emerging economies    61
5.2.4    CHALLENGES    62
5.2.4.1    Stringent regulatory environment    62
6    INDUSTRY INSIGHT S    63
6.1    TECHNOLOGY ANALYSIS    63
6.1.1    RECENT ADVANCES IN GASTROINTESTINAL STENTING TO OFFER IMPROVED STENT PATENCY AND REDUCED STENT-INDUCED COMPLICATIONS, RESULTING IN IMPROVED QUALITY OF LIFE    63
6.2    PRICING ANALYSIS    64
TABLE 5    PRICES FOR GI STENTS (USD)    64
6.3    VALUE CHAIN ANALYSIS    64
FIGURE 25    VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE    65
6.4    ECOSYSTEM MAPPING    65
FIGURE 26    GASTROINTESTINAL STENT MARKET: ECOSYSTEM ANALYSIS    66
6.5    SUPPLY CHAIN ANALYSIS    66
FIGURE 27    GASTROINTESTINAL STENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN    67
6.6    PORTER’S FIVE FORCES ANALYSIS    68
TABLE 6    GASTROINTESTINAL STENT MARKET: PORTER’S FIVE FORCES ANALYSIS    68
6.6.1    THREAT OF NEW ENTRANTS    68
6.6.1.1    High capital requirement    68
6.6.1.2    High preference for products from well-established brands    69
6.6.2    THREAT OF SUBSTITUTES    69
6.6.2.1    Substitute therapies for gastrointestinal stents    69
6.6.3    BARGAINING POWER OF SUPPLIERS    69
6.6.3.1    Presence of few raw material suppliers    69
6.6.3.2    Supplier switching cost    69
6.6.4    BARGAINING POWER OF BUYERS    69
6.6.4.1    Few companies offer premium products at global level    69
6.6.5    INTENSITY OF COMPETITIVE RIVALRY    70
6.6.5.1    Increasing demand for high-quality and innovative products    70
6.6.5.2    Lucrative growth potential in emerging markets    70

6.7    REGULATORY ANALYSIS    70
TABLE 7    INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE GASTROINTESTINAL STENT MARKET    70
6.7.1    NORTH AMERICA    71
6.7.1.1    US    71
TABLE 8    US FDA: CLASSIFICATION OF MEDICAL DEVICES    71
6.7.1.2    Canada    71
6.7.2    EUROPE    72
6.7.3    ASIA PACIFIC    72
6.7.3.1    India    72
6.7.3.2    China    72
TABLE 9    NMPA MEDICAL DEVICE CLASSIFICATION    73
6.7.3.3    Japan    73
TABLE 10    PMDA: CLASSIFICATION OF MEDICAL DEVICES    73
6.8    PATENT ANALYSIS    74
6.8.1    PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS    74
FIGURE 28    GLOBAL PATENT PUBLICATION TRENDS IN GASTROINTESTINAL STENT MARKET, 2015–2021    74
6.8.2    TOP APPLICANTS (COMPANIES) OF GASTROINTESTINAL STENTS PATENTS    75
FIGURE 29    TOP COMPANIES THAT APPLIED FOR GASTROINTESTINAL STENTS PATENTS, 2018 AND 2021    75
6.8.3    JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS
IN GASTROINTESTINAL STENT MARKET    75
FIGURE 30    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR GASTROINTESTINAL STENT PATENTS, 2015–2021    75
6.9    YC–YCC TRENDS/DISRUPTION IMPACTING CUSTOMER BUSINESS    76
FIGURE 31    YC–YCC SHIFT IN GASTROINTESTINAL STENT MARKET    76
6.10    IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET    77
TABLE 11    IMPACT OF COVID-19 ON SALES OF KEY MARKET PLAYERS    77
7    GASTROINTESTINAL STENT MARKET, BY PRODUCT    78
7.1    INTRODUCTION    79
FIGURE 32    BILIARY SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET
BY 2026    79
TABLE 12    GLOBAL GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    79
TABLE 13    GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    80
7.2    BILIARY STENTS    80
7.2.1    INCREASING PREVALENCE OF BILE DUCT CANCER AND CHRONIC
LIVER DISEASE TO DRIVE THE GROWTH OF THIS SEGMENT    80
TABLE 14    BILIARY STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS    81
TABLE 15    BILIARY STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    81

7.3    COLONIC STENTS    82
7.3.1    RISING DEMAND FOR COLONIC STENTS DUE TO HIGH INCIDENCE OF COLORECTAL CANCER TO DRIVE SEGMENT GROWTH    82
TABLE 16    COLONIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS    82
TABLE 17    COLONIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    83
7.4    DUODENAL STENTS    83
7.4.1    INCREASING PREVALENCE OF INTESTINAL MALIGNANCY TO ADOPT DUODENAL STENTS    83
TABLE 18    DUODENAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS    84
TABLE 19    DUODENAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    84
7.5    PANCREATIC STENTS    85
7.5.1    RISING NUMBER OF ERCP AND PTC PROCEDURES TO DRIVE
SEGMENT GROWTH    85
TABLE 20    PANCREATIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS    85
TABLE 21    PANCREATIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    86
7.6    ESOPHAGEAL STENTS    86
7.6.1    INCREASING INCIDENCE OF ESOPHAGEAL CANCER TO DRIVE ESOPHAGEAL STENTS MARKET    86
TABLE 22    ESOPHAGEAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS    87
TABLE 23    ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    87
8    GASTROINTESTINAL STENT MARKET, BY MATERIAL    88
8.1    INTRODUCTION    89
FIGURE 33    SELF-EXPANDING METAL STENTS SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET BY 2026    89
TABLE 24    GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    89
8.2    SELF-EXPANDING METAL STENTS    90
8.2.1    INCREASING ADOPTION OF SELF-EXPANDING METAL STENTS IN HOSPITAL SETTINGS TO DRIVE THE SEGMENT    90
TABLE 25    SELF-EXPANDING METAL STENTS: KEY PRODUCTS OFFERED
BY THE PROMINENT PLAYERS    90
TABLE 26    SELF-EXPANDING METAL STENTS MARKET, BY TYPE,
2019–2026 (USD MILLION)    91
TABLE 27    GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)    91
8.2.2    NITINOL STENTS    92
8.2.2.1    Ease of deployment for nitinol stents to drive segment growth    92
TABLE 28    NITINOL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS    92
TABLE 29    NITINOL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    93
8.2.3    STAINLESS STEEL STENTS    93
8.2.3.1    Excellent mechanical properties and medical efficiency of stainless-steel stents to support segment growth    93
TABLE 30    STAINLESS STEEL STENTS: KEY PRODUCTS OFFERED BY THE
PROMINENT PLAYERS    94
TABLE 31    STAINLESS STEEL STENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    94
8.2.4    OTHER METAL STENTS    95
TABLE 32    OTHER METAL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS    95
TABLE 33    OTHER METAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    95
8.3    PLASTIC STENTS    96
8.3.1    FAVORABLE REIMBURSEMENT POLICIES FOR PLASTIC STENTS AND INCREASED DEMAND FOR SHORT-TERM USE OF STENTS TO DRIVE
SEGMENT GROWTH    96
TABLE 34    PLASTIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS    96
TABLE 35    PLASTIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    97
9    GASTROINTESTINAL STENT MARKET, BY APPLICATION    98
9.1    INTRODUCTION    99
FIGURE 34    BILIARY DISEASES TO DOMINATE GASTROINTESTINAL STENT MARKET,
BY APPLICATION, IN 2026    99
TABLE 36    GASTROINTESTINAL STENT MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    99
9.2    BILIARY DISEASES    100
9.2.1    INCREASED AGING POPULATION AND PREVALENCE OF GALLSTONES
TO DRIVE GROWTH    100
TABLE 37    BILIARY DISEASES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    100
9.3    GASTROINTESTINAL CANCER    101
9.3.1    GASTROINTESTINAL CANCER IS THE LARGEST APPLICATION SEGMENT
FOR GASTROINTESTINAL STENT    101
TABLE 38    GASTROINTESTINAL CANCER STENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    101
TABLE 39    GASTROINTESTINAL CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    102
9.3.2    COLORECTAL CANCER    103
9.3.2.1    Rise of colorectal cancer cases to drive segment growth    103
TABLE 40    COLORECTAL CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    103
9.3.3    STOMACH CANCER    104
9.3.3.1    High incidence rate of stomach cancer to drive market share for stomach cancer    104
TABLE 41    STOMACH CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    104
9.3.4    PANCREATIC CANCER    105
9.3.4.1    Increased prevalence of pancreatic cancer and adoption of stents in endoscopic procedures to drive segment growth    105
TABLE 42    PANCREATIC CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    105
9.3.5    ESOPHAGEAL CANCER    106
9.3.5.1    Increasing number of esophageal cancer to increase adoption
of esophageal stents    106
TABLE 43    ESOPHAGEAL CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    106
9.4    IRRITABLE BOWEL SYNDROME    107
9.4.1    INCREASED PREVALENCE OF IRRITABLE BOWEL SYNDROME TO DRIVE DEMAND FOR GI STENTS    107
TABLE 44    IRRITABLE BOWEL SYNDROME STENT MARKET, BY COUNTRY/REGION, 2019–2026 (USD MILLION)    107
10    GASTROINTESTINAL STENT MARKET, BY END USER    108
10.1    INTRODUCTION    109
FIGURE 35    HOSPITALS & CLINICS SEGMENT TO DOMINATE GASTROINTESTINAL
STENT MARKET BY 2026    109
TABLE 45    GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    109
10.2    HOSPITALS & CLINICS    110
10.2.1    HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL STENTS IN HOSPITALS & CLINICS    110
TABLE 46    REIMBURSEMENT IN HOSPITAL OUTPATIENTS FOR ERCP STENTING PROCEDURES (USD)    111
TABLE 47    HOSPITALS & CLINICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)    111
10.3    AMBULATORY SURGICAL CENTERS    112
10.3.1    LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE AMBULATORY SURGICAL CENTERS    112
TABLE 48    US: NUMBER OF ASCS, (2013–2018)    112
TABLE 49    REIMBURSEMENT IN ASC FOR ERCP STENTING PROCEDURES (USD)    113
TABLE 50    AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    113
11    GASTROINTESTINAL STENT MARKET, BY REGION    114
11.1    INTRODUCTION    115
FIGURE 36    GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL SEGMENT DURING FORECAST PERIOD    115
TABLE 51    GASTROINTESTINAL STENT MARKET, BY REGION, 2019–2026 (USD MILLION)    116
11.2    NORTH AMERICA    116
TABLE 52    NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND 5 YEAR PREVALENCE ( 2020)    116
FIGURE 37    NORTH AMERICA: GASTROINTESTINAL STENT MARKET SNAPSHOT    117
TABLE 53    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    117
TABLE 54    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    118
TABLE 55    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    118
TABLE 56    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    118
TABLE 57    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    119
TABLE 58    NORTH AMERICA: GASTROINTESTINAL CANCER STENTS MARKET,
BY GASTROINTESTINAL CANCERS, 2019–2026 (USD MILLION)    119
TABLE 59    NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    119
11.2.1    US    120
11.2.1.1    US to dominate North America gastrointestinal stent market
during forecast period    120
TABLE 60    US: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER
BY GASTROINTESTINAL CANCER (2020)    120
TABLE 61    US: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    121
TABLE 62    US: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    121
TABLE 63    US: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    121
TABLE 64    US: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    122
TABLE 65    US: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    122
TABLE 66    US: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    122
11.2.2    CANADA    123
11.2.2.1    Growing geriatric population and increased incidence of gastrointestinal disorders to drive gastrointestinal stents demand    123
TABLE 67    CANADA: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER,
BY GASTROINTESTINAL CANCER (2020)    123
TABLE 68    CANADA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    123
TABLE 69    CANADA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    124
TABLE 70    CANADA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    124
TABLE 71    CANADA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    124
TABLE 72    CANADA: GASTROINTESTINAL CANCER STENTS MARKET,
BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    125
TABLE 73    CANADA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    125
11.3    EUROPE    125
TABLE 74    EUROPE: GASTROINTESTINAL CANCER INCIDENCE, BY GASTROINTESTINAL CANCER (2020)    125
FIGURE 38    EUROPE: GASTROINTESTINAL STENT MARKET SNAPSHOT    126
TABLE 75    EUROPE: GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    127
TABLE 76    EUROPE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    127
TABLE 77    EUROPE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    127
TABLE 78    EUROPE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    128
TABLE 79    EUROPE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    128
TABLE 80    EUROPE: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    128
TABLE 81    EUROPE: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    129
11.3.1    GERMANY    129
11.3.1.1    Germany dominated the European gastrointestinal stent
market in 2020    129
TABLE 82    GERMANY: GI CANCER INCIDENCE, IN 2020    129
TABLE 83    GERMANY: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    130
TABLE 84    GERMANY: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    130
TABLE 85    GERMANY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    130
TABLE 86    GERMANY: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    131
TABLE 87    GERMANY: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    131
TABLE 88    GERMANY: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    131
11.3.2    FRANCE    132
11.3.2.1    Favorable statutory health insurance system to boost gastrointestinal stents adoption    132
TABLE 89    FRANCE: GI CANCER INCIDENCE, (2020)    132
TABLE 90    FRANCE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    132
TABLE 91    FRANCE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    133
TABLE 92    FRANCE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    133
TABLE 93    FRANCE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    133
TABLE 94    FRANCE: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    134
TABLE 95    FRANCE: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    134
11.3.3    UK    134
11.3.3.1    Increased incidence of gastrointestinal cancers and minimally invasive surgeries to increase gastrointestinal stents adoption    134
TABLE 96    UK: GASTROINTESTINAL CANCER INCIDENCE (2020)    135
TABLE 97    UK: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    135
TABLE 98    UK: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    136
TABLE 99    UK: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL,
2019–2026 (USD MILLION)    136
TABLE 100    UK: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    136
TABLE 101    UK: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    137
TABLE 102    UK: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    137
11.3.4    ITALY    137
11.3.4.1    Aging population and initiatives to build awareness about digestive health to increase gastrointestinal stent adoption    137
TABLE 103    ITALY: GASTROINTESTINAL CANCER INCIDENCE (2020)    138
TABLE 104    ITALY: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    138
TABLE 105    ITALY: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    139
TABLE 106    ITALY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    139
TABLE 107    ITALY: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    139
TABLE 108    ITALY: GASTROINTESTINAL CANCER STENT MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    140
TABLE 109    ITALY: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    140
11.3.5    SPAIN    140
11.3.5.1    Increased prevalence of gastrointestinal diseases to raise demand for gastrointestinal stent    140
TABLE 110    SPAIN: GASTROINTESTINAL CANCER INCIDENCE (2020)    140
TABLE 111    SPAIN: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    141
TABLE 112    SPAIN: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    141
TABLE 113    SPAIN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    142
TABLE 114    SPAIN: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    142
TABLE 115    SPAIN: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    142
TABLE 116    SPAIN: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    143
11.3.6    REST OF EUROPE    143
TABLE 117    ROE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    144
TABLE 118    ROE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    144
TABLE 119    ROE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
 BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    144
TABLE 120    ROE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    145
TABLE 121    ROE: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    145
TABLE 122    ROE: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    145
11.4    ASIA PACIFIC    146
TABLE 123    ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE (2020)    146
FIGURE 39    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET SNAPSHOT    147
TABLE 124    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    147
TABLE 125    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    148
TABLE 126    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    148
TABLE 127    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    148
TABLE 128    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    149
TABLE 129    ASIA PACIFIC: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    149
TABLE 130    ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    149
11.4.1    CHINA    150
11.4.1.1    Increasing healthcare expenditure and government initiatives to modernize healthcare system and support market growth    150
TABLE 131    CHINA: GASTROINTESTINAL CANCER INCIDENCE, (2020)    150
TABLE 132    CHINA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    151
TABLE 133    CHINA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    151
TABLE 134    CHINA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    151
TABLE 135    CHINA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    152
TABLE 136    CHINA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    152
TABLE 137    CHINA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    152
11.4.2    JAPAN    153
11.4.2.1    Strong healthcare system and increased geriatric population
to drive market growth    153
TABLE 138    JAPAN: GASTROINTESTINAL CANCER INCIDENCE (2020)    153
TABLE 139    JAPAN: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    154
TABLE 140    JAPAN: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    154
TABLE 141    JAPAN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    154
TABLE 142    JAPAN: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    155
TABLE 143    JAPAN: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    155
TABLE 144    JAPAN: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    155
11.4.3    INDIA    156
11.4.3.1    Increasing prevalence of gastrointestinal disorders and presence of global and local market players to drive market growth    156
TABLE 145    INDIA: GASTROINTESTINAL CANCER INCIDENCE (2020)    156
TABLE 146    INDIA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    156
TABLE 147    INDIA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    157
TABLE 148    INDIA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    157
TABLE 149    INDIA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    157
TABLE 150    INDIA: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    158
TABLE 151    INDIA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    158
11.4.4    REST OF ASIA PACIFIC    158
TABLE 152    ROAPAC: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    159
TABLE 153    ROAPAC: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    159
TABLE 154    ROAPAC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    159
TABLE 155    ROAPAC: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION)    160
TABLE 156    ROAPAC: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    160
TABLE 157    ROAPAC: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    160
11.5    LATIN AMERICA    161
11.5.1    INCREASING DISPOSABLE INCOME AND BURDEN OF GASTRIC
CANCER TO DRIVE MARKET GROWTH    161
TABLE 158    LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, 2020    161
TABLE 159    BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, 2020    161
TABLE 160    LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    162
TABLE 161    LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION)    162
TABLE 162    LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    162
TABLE 163    LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019–2026 (USD MILLION)    163
TABLE 164    LATIN AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    163
TABLE 165    LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION)    163
11.6    MIDDLE EAST & AFRICA    164
11.6.1    MIDDLE EAST & AFRICA IS THE SMALLEST MARKET FOR GASTROINTESTINAL STENT PRODUCTS    164
TABLE 166    MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020)    164
TABLE 167    MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION)    164
TABLE 168    MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019–2026 (USD MILLION)    165
TABLE 169    MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION)    165
TABLE 170    MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)    165
TABLE 171    MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,
BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION)    166
TABLE 172    MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,
BY END USER, 2019–2026 (USD MILLION)    166
12    COMPETITIVE LANDSCAPE    167
12.1    OVERVIEW    167
12.2    KEY PLAYER STRATEGIES    167
12.3    REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS    168
12.4    KEY PLAYERS RANKING (2020)    168
FIGURE 41    MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020    168
12.5    COMPETITIVE BENCHMARKING    170
12.5.1    COMPANY FOOTPRINT FOR KEY PLAYERS    170
12.5.2    PRODUCT AND REGIONAL FOOTPRINT OF COMPANIES
IN GASTROINTESTINAL STENT MARKET    171
TABLE 173    PRODUCT TYPE FOOTPRINT OF COMPANIES (20 MARKET PLAYERS)    172
TABLE 174    MATERIAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS)    173
TABLE 175    REGIONAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS)    174
12.6    COMPETITIVE LEADERSHIP MAPPING    175
12.6.1    STARS    175
12.6.2    EMERGING LEADERS    175
12.6.3    PERVASIVE PLAYERS    175
12.6.4    PARTICIPANTS    176
FIGURE 42    GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP
MAPPING (2020)    176
12.7    COMPETITIVE LEADERSHIP MAPPING FOR START-UPS    177
12.7.1    PROGRESSIVE COMPANIES    177
12.7.2    DYNAMIC COMPANIES    177
12.7.3    STARTING BLOCKS    177
12.7.4    RESPONSIVE COMPANIES    177
FIGURE 43    GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP
MAPPING FOR START-UPS (2020)    178
12.8    COMPETITIVE SCENARIO    178
12.8.1    PRODUCT LAUNCHES & APPROVALS    178
TABLE 176    GASTROINTESTINAL STENT MARKET: KEY PRODUCT LAUNCHES
& APPROVALS, 2018–2021    178
12.8.2    DEALS    179
TABLE 177    GASTROINTESTINAL STENT MARKET: KEY DEALS, 2018–2021    179
13    COMPANY PROFILES    180
13.1    KEY PLAYERS    180
(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats)*
13.1.1    BOSTON SCIENTIFIC CORPORATION    180
TABLE 178    BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW    180
FIGURE 44    BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)    181
13.1.2    COOK GROUP    183
TABLE 179    COOK GROUP: BUSINESS OVERVIEW    183
13.1.3    TAEWOONG MEDICAL    186
TABLE 180    TAEWOONG MEDICAL: BUSINESS OVERVIEW    186
13.1.4    MICRO-TECH (NANJING) CO., LTD.    188
TABLE 181    MICRO-TECH (NANJING) CO., LTD.: BUSINESS OVERVIEW    188
13.1.5    OLYMPUS CORPORATION    189
TABLE 182    OLYMPUS CORPORATION: BUSINESS OVERVIEW    189
FIGURE 45    OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)    190
13.2    OTHER PLAYERS    192
13.2.1    MERIT MEDICAL SYSTEMS    192
TABLE 183    MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW    192
FIGURE 46    MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT    193
13.2.2    BECTON, DICKINSON AND COMPANY    195
TABLE 184    BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW    195
FIGURE 47    BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT (2020)    196
13.2.3    MEDTRONIC    197
TABLE 185    MEDTRONIC: BUSINESS OVERVIEW    197
FIGURE 48    MEDTRONIC: COMPANY SNAPSHOT (2020)    198
13.2.4    CANTEL MEDICAL    199
TABLE 186    CANTEL MEDICAL: BUSINESS OVERVIEW    199
FIGURE 49    CANTEL MEDICAL: COMPANY SNAPSHOT (2020)    200
13.2.5    CONMED CORPORATION    202
TABLE 187    CONMED CORPORATION: BUSINESS OVERVIEW    202
FIGURE 50    CONMED CORPORATION: COMPANY SNAPSHOT (2020)    203
13.2.6    ELLA-CS, S.R.O.    204
TABLE 188    ELLA-CS, S.R.O.: BUSINESS OVERVIEW    204
13.2.7    ENDO-FLEX GMBH    206
TABLE 189    ENDO-FLEX GMBH: BUSINESS OVERVIEW    206
13.2.8    MI-TECH    207
TABLE 190    MI-TECH : BUSINESS OVERVIEW    207
13.2.9    HOBBS MEDICAL INC.    209
TABLE 191    HOBBS MEDICAL INC.: BUSINESS OVERVIEW    209
13.2.10    QUALIMED    210
TABLE 192    QUALIMED: BUSINESS OVERVIEW    210
13.2.11    UK MEDICAL    211
TABLE 193    UK MEDICAL: BUSINESS OVERVIEW    211
13.2.12    CITEC    212
TABLE 194    CITEC: BUSINESS OVERVIEW    212
13.2.13    MEDORAH MEDITEK PVT. LTD.    213
TABLE 195    MEDORAH MEDITEK PVT. LTD.: BUSINESS OVERVIEW    213
13.2.14    BCM CORPORATION    214
TABLE 196    BCM CORPORATION: BUSINESS OVERVIEW    214
13.2.15    LEUFEN MEDICAL GMBH    215
TABLE 197    LEUFEN MEDICAL GMBH: BUSINESS OVERVIEW    215
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14    APPENDIX    216
14.1    DISCUSSION GUIDE    216
14.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    220
14.3    AVAILABLE CUSTOMIZATIONS    222
14.4    RELATED REPORTS    222
14.5    AUTHOR DETAILS    223"